DE69131100T2 - Topische, ophtalmische suspensionen - Google Patents

Topische, ophtalmische suspensionen

Info

Publication number
DE69131100T2
DE69131100T2 DE69131100T DE69131100T DE69131100T2 DE 69131100 T2 DE69131100 T2 DE 69131100T2 DE 69131100 T DE69131100 T DE 69131100T DE 69131100 T DE69131100 T DE 69131100T DE 69131100 T2 DE69131100 T2 DE 69131100T2
Authority
DE
Germany
Prior art keywords
topical
eye
ophtalmic
suspensions
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69131100T
Other languages
English (en)
Other versions
DE69131100D1 (de
Inventor
Santosh Chandrasekaran
Margaret Reents
John Babcock
Lyle Bowman
Roy Archibald
Joseph Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Inc
Original Assignee
Insite Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insite Vision Inc filed Critical Insite Vision Inc
Application granted granted Critical
Publication of DE69131100D1 publication Critical patent/DE69131100D1/de
Publication of DE69131100T2 publication Critical patent/DE69131100T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69131100T 1990-07-06 1991-06-25 Topische, ophtalmische suspensionen Expired - Lifetime DE69131100T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/549,093 US5188826A (en) 1988-02-08 1990-07-06 Topical ophthalmic suspensions
PCT/US1991/004350 WO1992000707A1 (en) 1990-07-06 1991-06-25 Topical ophthalmic suspensions

Publications (2)

Publication Number Publication Date
DE69131100D1 DE69131100D1 (de) 1999-05-12
DE69131100T2 true DE69131100T2 (de) 1999-08-12

Family

ID=24191632

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131100T Expired - Lifetime DE69131100T2 (de) 1990-07-06 1991-06-25 Topische, ophtalmische suspensionen

Country Status (13)

Country Link
US (1) US5188826A (de)
EP (1) EP0538313B1 (de)
JP (1) JP3284548B2 (de)
AT (1) ATE178476T1 (de)
AU (1) AU8184991A (de)
CA (1) CA2086120C (de)
DE (1) DE69131100T2 (de)
DK (1) DK0538313T3 (de)
ES (1) ES2132088T3 (de)
GR (1) GR3030381T3 (de)
NZ (1) NZ238850A (de)
WO (1) WO1992000707A1 (de)
ZA (1) ZA915220B (de)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521222A (en) * 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5461081A (en) * 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
US5505953A (en) 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
WO1994017538A2 (en) * 1993-01-21 1994-08-04 Mayo Foundation For Medical Education And Research Microparticle switching devices
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5654006A (en) * 1993-02-12 1997-08-05 Mayo Foundation For Medical Education And Research Condensed-phase microparticle composition and method
US5753261A (en) * 1993-02-12 1998-05-19 Access Pharmaceuticals, Inc. Lipid-coated condensed-phase microparticle composition
US5820879A (en) * 1993-02-12 1998-10-13 Access Pharmaceuticals, Inc. Method of delivering a lipid-coated condensed-phase microparticle composition
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
WO1995024430A2 (en) 1994-03-04 1995-09-14 University Of Washington Block and graft copolymers and methods relating thereto
US5773021A (en) * 1994-03-14 1998-06-30 Vetoquinol S.A. Bioadhesive ophthalmic insert
FR2717691B1 (fr) * 1994-03-22 1998-02-13 Europhta Laboratoire Nouveaux gels ophtalmiques et leur procédé d'obtention.
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
US5518732A (en) * 1995-02-14 1996-05-21 Chiron Vision, Inc. Bio-erodible ophthalmic shield
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
FR2742336B1 (fr) * 1995-12-19 1998-03-06 Chauvin Lab Sa Collyre destine notamment au traitement de l'oeil sec
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
WO1999006023A1 (en) * 1997-07-29 1999-02-11 Alcon Laboratories, Inc. Ophthalmic compositions containing galactomannan polymers and borate
US6159458A (en) * 1997-11-04 2000-12-12 Insite Vision Sustained release ophthalmic compositions containing water soluble medicaments
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR022119A1 (es) * 1998-12-22 2002-09-04 Bausch & Lomb Composiciones que contienen feniramina y metodo para el tratamiento de las respuestas alergicas
WO2000042986A2 (de) * 1999-01-19 2000-07-27 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Künstliche tränenflüssigkeit in gelform
US6258350B1 (en) 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US6699492B2 (en) * 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
ITMI991453A1 (it) * 1999-07-01 2001-01-01 Farmila Farma Milano Composizioni oftalmiche in forma di gel acquosi
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
HUP0001769A2 (hu) * 2000-05-04 2002-01-28 dr. Kahán Ilona Molnárné Lakrofil készítmény alkalmazása gyógyászati hatóanyag-tartalmú szemcseppekben
AR035509A1 (es) * 2000-12-21 2004-06-02 Alcon Inc Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein
US20040214754A1 (en) * 2001-10-03 2004-10-28 Ellis Edward J. Ophthalmic preparation containing glycomacropeptide
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
US20050143471A1 (en) * 2001-10-22 2005-06-30 Shen Gao Taste masking spill-resistant formulation
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US20030099294A1 (en) * 2001-11-27 2003-05-29 Limin Wang Picture level adaptive frame/field coding for digital video content
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
US6982079B2 (en) * 2002-04-26 2006-01-03 Allergan, Inc. Compositions for treating hyperemia
MXPA05000186A (es) * 2002-07-03 2005-08-17 Pericor Science Inc Composiciones de acido hialuronico y metodos de uso.
US6806364B2 (en) * 2002-07-29 2004-10-19 Ast Products, Inc. Ophthalmic compositions
US6828356B2 (en) * 2002-07-29 2004-12-07 Ast Products, Inc. Preparation of ophthalmic compositions
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US7914803B2 (en) 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
KR101147046B1 (ko) 2003-06-13 2012-05-22 알콘, 인코퍼레이티드 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
US20050202097A1 (en) * 2004-03-12 2005-09-15 Melbj Holdings, Llc, Florida Lubricant for the ocular surface
US8455016B2 (en) 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
CA2567418C (en) * 2004-05-27 2012-12-04 Santen Pharmaceutical Co., Ltd. Viscous agent for ophthalmic use
JP4736540B2 (ja) * 2004-05-27 2011-07-27 参天製薬株式会社 眼科用粘稠化剤
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
DE602005015872D1 (de) 2004-07-15 2009-09-17 Gynaecologiq B V Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
TWI393567B (zh) 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法
TW200722109A (en) * 2005-03-31 2007-06-16 Bausch & Lomb Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
BRPI0618643A2 (pt) 2005-11-09 2011-09-06 Combinatorx Inc composição compreendendo um par de fármacos, composição compreendendo um corticosteróide e um imunossupressor dependente de imunofilina não-esteróide, kits e uso
WO2007070463A2 (en) * 2005-12-12 2007-06-21 Riolan Technologies, Inc. Compositions, methods and kits for removing debris from an ocular area
JP2009533455A (ja) * 2006-04-12 2009-09-17 マサチューセッツ インスティテュート オブ テクノロジー 癒着を阻害するための組成物および方法
CA2650592A1 (en) 2006-04-26 2007-11-08 Aciex, Inc. Compositions for the treatment and prevention of eyelid swelling
WO2008035246A2 (en) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
US9132071B2 (en) * 2006-07-28 2015-09-15 Santen Sas Compositions containing quaternary ammonium compounds
US20080026013A1 (en) * 2006-07-28 2008-01-31 Laura Rabinovich-Guilatt Compositions containing quaternary ammonium compounds
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
TWI415629B (zh) * 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法
ES2667945T3 (es) * 2007-10-08 2018-05-16 Aurinia Pharmaceuticals Inc. Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR
WO2009061431A2 (en) * 2007-11-08 2009-05-14 Aciex Therapeutics, Inc. Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
US8501800B2 (en) * 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
WO2010107689A1 (en) 2009-03-17 2010-09-23 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
JP2012529509A (ja) * 2009-06-09 2012-11-22 ラックス・バイオサイエンシーズ・インコーポレイテッド 眼科用用途のための局所薬物送達システム
JP4777477B2 (ja) 2009-09-30 2011-09-21 ロート製薬株式会社 点眼剤
NL2003660C2 (en) 2009-10-16 2011-04-19 Giskit B V Composition and method for medical imaging of body cavities.
PT2965749T (pt) 2009-12-03 2018-10-09 Novartis Ag Supensões de nanopartículas contendo um polímero de carboxivinilo
US20120165272A1 (en) 2010-12-21 2012-06-28 Recopharma Ab Tear Substitutes
WO2013046059A2 (en) * 2011-09-27 2013-04-04 Sykora Robert C Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose
WO2014135984A2 (en) 2013-03-07 2014-09-12 Recopharma Ab Glycosylated mucin-immunoglobulin fusion protein coated device
US20140377210A1 (en) * 2013-06-21 2014-12-25 Gnt, Llc Artificial tear compositions
JP6703408B2 (ja) * 2016-01-30 2020-06-03 国立大学法人 筑波大学 ポリイオンコンプレックスを有効成分とするドライアイ処置用組成物
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
WO2020138135A1 (ja) * 2018-12-26 2020-07-02 ライオン株式会社 眼科用組成物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947573A (en) * 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
GB2013084B (en) * 1978-01-25 1982-07-28 Alcon Lab Inc Ophthalmic drug dosage
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
DE2854279A1 (de) * 1978-12-15 1980-07-03 Thilo & Co Gmbh Dr Antiglaukompraeparat
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
EP0145714A1 (de) * 1983-05-25 1985-06-26 Alcon Laboratories, Inc. Ophthalmisches gel
EP0145710A1 (de) * 1983-05-25 1985-06-26 Alcon Laboratories, Inc. Ophthalmische lösung
JPS6099257A (ja) * 1983-11-04 1985-06-03 ライオン株式会社 皮膚損傷面保護具
ATE151286T1 (de) * 1983-11-14 1997-04-15 Columbia Lab Inc Bioadhäsive mittel
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
DE3440352A1 (de) * 1984-11-05 1986-05-07 Dr. Thilo & Co GmbH, 8029 Sauerlach Dry-eye-packung
US4826871A (en) * 1985-03-13 1989-05-02 Gressel Philip D Topical ophthalmic compositions containing one or more retinoids
US4820737A (en) * 1987-02-17 1989-04-11 University Of Iowa Research Foundation Lacrimal secretion stimulant (lss)
IE63392B1 (en) * 1988-02-08 1995-04-19 Insite Vision Inc Ophthalmic suspensions
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use

Also Published As

Publication number Publication date
NZ238850A (en) 1992-11-25
GR3030381T3 (en) 1999-09-30
CA2086120A1 (en) 1992-01-07
ZA915220B (en) 1992-08-26
WO1992000707A1 (en) 1992-01-23
JPH05508840A (ja) 1993-12-09
EP0538313B1 (de) 1999-04-07
DK0538313T3 (da) 1999-10-18
ES2132088T3 (es) 1999-08-16
EP0538313A1 (de) 1993-04-28
JP3284548B2 (ja) 2002-05-20
AU8184991A (en) 1992-02-04
US5188826A (en) 1993-02-23
CA2086120C (en) 2001-09-04
DE69131100D1 (de) 1999-05-12
ATE178476T1 (de) 1999-04-15
EP0538313A4 (de) 1994-04-13

Similar Documents

Publication Publication Date Title
DE69131100D1 (de) Topische, ophtalmische suspensionen
DE69126134D1 (de) Ophtalmische suspensionen
MX9603435A (es) Sistema de aplicacion oftalmica liquida de liberacion sostenida.
NO894001D0 (no) Optalmiske suspensjoner.
DE69424275T2 (de) Alkalische ophthalmische suspensionen
AR246167A1 (es) Una composicion de bajas calorias substitutiva de las grasas comestibles y composiciones alimenticias que la contienen.
LU92301I2 (fr) "Nepafenac - suspension ophtalmique"
MX9603918A (es) Composicion oftalmica con viscosidad disminuida.
CA2045425A1 (en) Powdered superabsorbents, containing silica, their preparation process and their use
MY135004A (en) Topical ophthalmic suspensions
AABERG et al. Recurrences and Bilaterality in the Multiple Evanescent White-Dot Syndrome: Reply
ES512751A0 (es) "procedimiento para la preparacion de un colirio antiseptico para afecciones oculares".

Legal Events

Date Code Title Description
8364 No opposition during term of opposition